Mathilde Kaper

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

Jennifer L. McQuade, Carrie R. Daniel, Kenneth R. Hess et al. · The Lancet Oncology · 2018 · 658 citations · Full text

Medicine, Dermatology, Oncology +14

Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1

Fabrice André, Eva Ciruelos, Dejan Juric et al. · Annals of Oncology · 2020 · 599 citations · Full text

Medicine, Oncology, Pharmacology +17

Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials

Dirk Schadendorf, Georgina V. Long, D. Stroiakovski et al. · European Journal of Cancer · 2017 · 171 citations

Medicine, Oncology, Pharmacology +8

Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies

Andrew Gammie, Mathilde Kaper, Caroline A. Dorrepaal et al. · European Urology · 2015 · 166 citations

Medicine, Physiology, Urology +17

Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study

Elena Lukina, Nora Watman, Elsa Ávila Arreguin et al. · Blood · 2010 · 157 citations · Full text

Medicine, Hematology, Pharmacotherapy +3